Johnny-biofrontera shares are handling dnaprint's need for cash...no forward or reverse split needed. Unless m2gen buys dnaprint shares off of the market and significantly lowers total shares outstanding and dnaprint wants to foward split to help investors from the past... That seems unlikely.. Too My opinion stays at no splits and .25 to .5 during March 07. if the stock does not go up, perhaps I could see m2gen buying dnaprint shares up from the market. Just say 1million bought in shares at say .02 would eat up 50million shares. M2gen could just hold the shares for quite a nice future asset! Merck could also take a stake in dnag and then we could see significantly higher prices.. Drug co's do buy each other's stock from time to time.